Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Clinical trial NCT01335698 · COMPLETED
Trial details
- NCT number
- NCT01335698
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-27
- Primary completion
- 2014-09-10
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.